We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Stem Cell Therapy is Safe: Reprogramming Does Not Increase the Rate of Mutagenesis

By LabMedica International staff writers
Posted on 22 Feb 2017
Print article
Image: Induced pluripotent stem cells (iPSCs) are the basis of a technique that opens the doors to many medical advances involving repair and restoration of tissues and organs (Photo courtesy of Darryl Leja, National Human Genome Research Institute).
Image: Induced pluripotent stem cells (iPSCs) are the basis of a technique that opens the doors to many medical advances involving repair and restoration of tissues and organs (Photo courtesy of Darryl Leja, National Human Genome Research Institute).
DNA mapping studies have shown that the genomes of induced pluripotent stem cells do not contain more mutations that did the original cell line from which they were generated.

One important unsolved question in the stem cell field is, do induced pluripotent stem cells (iPSCs) have more mutations than other cultured somatic cells because of the reprogramming process? The delay in answering this question has slowed adoption of iPSCs in biomedical research and medicine, as concerns that these cells are prone to increased numbers of genetic mutations persist.

Investigators at the [U.S.] National Human Genome Research Institute adopted a unique approach to answering the question of the possible increase in mutation rate in iSPCs by deriving fibroblast subclones and clonal iPSC lines from the same fibroblast population. This provided the investigators with parallel cell lines from the same source, only one of which having undergone the process to turn them into iPSCs.

The investigators applied next-generation sequencing to compare genomic variations in these lines. They reported in the February 6, 2017, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences that targeted deep sequencing of parental fibroblasts revealed that most variants detected in clonal iPSCs and fibroblast subclones were rare variants inherited from the parental fibroblasts. More than 90% of these mutations were random, preexisting sequence variants in small subsets of the parental fibroblast population. This data strongly suggested that reprogramming process was not mutagenic.

"This technology will eventually change how doctors treat diseases. These findings suggest that the question of safety should not impede research using iPSC," said senior author Dr. Paul Liu, senior investigator in the Translational and Functional Genomics Branch of the [U.S.] National Human Genome Research Institute.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.